GlassScriptPhysician profile
Candace D Charles
NPI 1922284504
$6,455.82
in general payments reported to CMS, 2019-2025
27 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,482 · 2022: $1,147 · 2023: $1,251 · 2024: $1,259 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,814 · Entertainment: $13.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,813.80 |
| Entertainment | $13.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,630.49 | 2021-2025 | Relistor, Trulance |
| Abbott Laboratories | $1,344.83 | 2021-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $549.62 | 2021-2025 | Xtampza, Belbuca |
| Abbvie INC. | $520.97 | 2021-2025 | |
| Biotronik Nro, INC. | $291.45 | 2023-2025 | Prospera, Biotronik |
| Vertos Medical, INC. | $283.86 | 2021-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $255.74 | 2021-2025 | Sprint Pns System |
| Medtronic, INC. | $248.88 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Foundation Fusion Solutions, LLC | $232.44 | 2024-2025 | |
| Valinor Pharma, LLC | $173.91 | 2023-2025 | Movantik |
| Boston Scientific Corporation | $153.75 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $109.66 | 2021 | |
| Lilly USA, LLC | $108.63 | 2021-2025 | Zepbound |
| Vertex Pharmaceuticals Incorporated | $81.98 | 2024-2025 | |
| Depuy Synthes Sales INC. | $74.53 | 2025 | Monovisc, Orthovisc |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $71.35 | 2021-2022 | |
| Nevro Corp. | $57.18 | 2021-2023 | Senza |
| Biodelivery Sciences International, INC. | $51.95 | 2021 | |
| Painteq LLC | $44.98 | 2024 | Painteq |
| Biohaven Pharmaceutical Holding Company LTD. | $39.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.08 | 2021 | |
| Pfizer INC. | $26.89 | 2023 | |
| Redhill Biopharma INC. | $16.56 | 2021 | |
| Optinose US, INC. | $15.71 | 2021 | |
| Azurity Pharmaceuticals, INC. | $14.27 | 2024 | Horizant |
| Ibsa Pharma INC. | $13.39 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Charles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.